191 related articles for article (PubMed ID: 11468274)
1. Processing of beta-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex.
Yamada H; Saito F; Fukuta-Ohi H; Zhong D; Hase A; Arai K; Okuyama A; Maekawa R; Shimizu T; Matsumura K
Hum Mol Genet; 2001 Jul; 10(15):1563-9. PubMed ID: 11468274
[TBL] [Abstract][Full Text] [Related]
2. Disruption of dystroglycan axis by beta-dystroglycan processing in cardiomyopathic hamster muscle.
Matsumura K; Arai K; Zhong D; Saito F; Fukuta-Ohi H; Maekawa R; Yamada H; Shimizu T
Neuromuscul Disord; 2003 Dec; 13(10):796-803. PubMed ID: 14678802
[TBL] [Abstract][Full Text] [Related]
3. Proteolysis of beta-dystroglycan in muscular diseases.
Matsumura K; Zhong D; Saito F; Arai K; Adachi K; Kawai H; Higuchi I; Nishino I; Shimizu T
Neuromuscul Disord; 2005 May; 15(5):336-41. PubMed ID: 15833425
[TBL] [Abstract][Full Text] [Related]
4. Dystroglycan distribution in adult mouse brain: a light and electron microscopy study.
Zaccaria ML; Di Tommaso F; Brancaccio A; Paggi P; Petrucci TC
Neuroscience; 2001; 104(2):311-24. PubMed ID: 11377836
[TBL] [Abstract][Full Text] [Related]
5. Spatial relationship of the C-terminal domains of dystrophin and beta-dystroglycan in cardiac muscle support a direct molecular interaction at the plasma membrane interface.
Stevenson S; Rothery S; Cullen MJ; Severs NJ
Circ Res; 1998 Jan 9-23; 82(1):82-93. PubMed ID: 9440707
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of β-dystroglycan occurs in sarcoglycan-deficient skeletal muscle without MMP-2 and MMP-9.
Fukai Y; Ohsawa Y; Ohtsubo H; Nishimatsu SI; Hagiwara H; Noda M; Sasaoka T; Murakami T; Sunada Y
Biochem Biophys Res Commun; 2017 Oct; 492(2):199-205. PubMed ID: 28821434
[TBL] [Abstract][Full Text] [Related]
7. Direct interaction of beta-dystroglycan with F-actin.
Chen YJ; Spence HJ; Cameron JM; Jess T; Ilsley JL; Winder SJ
Biochem J; 2003 Oct; 375(Pt 2):329-37. PubMed ID: 12892561
[TBL] [Abstract][Full Text] [Related]
8. Effect of beta-dystroglycan processing on utrophin/Dp116 anchorage in normal and mdx mouse Schwann cell membrane.
Hnia K; Hugon G; Masmoudi A; Mercier J; Rivier F; Mornet D
Neuroscience; 2006 Aug; 141(2):607-620. PubMed ID: 16735092
[TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of the epithelial dystroglycan complex.
Durbeej M; Campbell KP
J Biol Chem; 1999 Sep; 274(37):26609-16. PubMed ID: 10473626
[TBL] [Abstract][Full Text] [Related]
10. A stoichiometric complex of neurexins and dystroglycan in brain.
Sugita S; Saito F; Tang J; Satz J; Campbell K; Südhof TC
J Cell Biol; 2001 Jul; 154(2):435-45. PubMed ID: 11470830
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the protease activity that cleaves the extracellular domain of beta-dystroglycan.
Zhong D; Saito F; Saito Y; Nakamura A; Shimizu T; Matsumura K
Biochem Biophys Res Commun; 2006 Jun; 345(2):867-71. PubMed ID: 16701552
[TBL] [Abstract][Full Text] [Related]
12. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.
Michele DE; Barresi R; Kanagawa M; Saito F; Cohn RD; Satz JS; Dollar J; Nishino I; Kelley RI; Somer H; Straub V; Mathews KD; Moore SA; Campbell KP
Nature; 2002 Jul; 418(6896):417-22. PubMed ID: 12140558
[TBL] [Abstract][Full Text] [Related]
13. The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle.
Bowe MA; Mendis DB; Fallon JR
J Cell Biol; 2000 Feb; 148(4):801-10. PubMed ID: 10684260
[TBL] [Abstract][Full Text] [Related]
14. Formation of multiple complexes between beta-dystroglycan and dystrophin family products.
Royuela M; Chazalette D; Hugon G; Paniagua R; Guerlavais V; Fehrentz JA; Martinez J; Labbe JP; Rivier F; Mornet D
J Muscle Res Cell Motil; 2003; 24(7):387-97. PubMed ID: 14677641
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the transmembrane molecular architecture of the dystroglycan complex in schwann cells.
Saito F; Masaki T; Kamakura K; Anderson LV; Fujita S; Fukuta-Ohi H; Sunada Y; Shimizu T; Matsumura K
J Biol Chem; 1999 Mar; 274(12):8240-6. PubMed ID: 10075729
[TBL] [Abstract][Full Text] [Related]
16. Podocyte flattening and disorder of glomerular basement membrane are associated with splitting of dystroglycan-matrix interaction.
Kojima K; Davidovits A; Poczewski H; Langer B; Uchida S; Nagy-Bojarski K; Hovorka A; Sedivy R; Kerjaschki D
J Am Soc Nephrol; 2004 Aug; 15(8):2079-89. PubMed ID: 15284294
[TBL] [Abstract][Full Text] [Related]
17. Defective glycosylation in muscular dystrophy.
Muntoni F; Brockington M; Blake DJ; Torelli S; Brown SC
Lancet; 2002 Nov; 360(9343):1419-21. PubMed ID: 12424008
[TBL] [Abstract][Full Text] [Related]
18. The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan.
Rentschler S; Linn H; Deininger K; Bedford MT; Espanel X; Sudol M
Biol Chem; 1999 Apr; 380(4):431-42. PubMed ID: 10355629
[TBL] [Abstract][Full Text] [Related]
19. The interaction of dystrophin with beta-dystroglycan is regulated by tyrosine phosphorylation.
Ilsley JL; Sudol M; Winder SJ
Cell Signal; 2001 Sep; 13(9):625-32. PubMed ID: 11495720
[TBL] [Abstract][Full Text] [Related]
20. Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton.
Henry MD; Campbell KP
Curr Opin Cell Biol; 1996 Oct; 8(5):625-31. PubMed ID: 8939660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
